Metabolites
Displaying metabolites 1226 - 1250 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB23251 | DG(12:0/12:0/0:0) | 3-(dodecanoyloxy)-2-hydroxypropyl dodecanoate | 456.708 C27H52O5 | ||
ECMDB23259 | DG(14:0/10:0/0:0) | (2R)-3-(decanoyloxy)-2-hydroxypropyl tetradecanoate | 456.708 C27H52O5 | ||
ECMDB01354 | 5,10-Methylene-THF 31690-11-6 | (2S)-2-({4-[(6aR)-3-amino-1-oxo-1H,2H,5H,6H,6aH,7H,8H,9H-imidazolidino[1,5-f]pteridin-8-yl]phenyl}formamido)pentanedioic acid | 457.4399 C20H23N7O6 | ||
ECMDB01142 | FMNH | [(5-{7,8-dimethyl-2,4-dioxo-1H,2H,3H,4H,5H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl)oxy]phosphonic acid | 458.3597 C17H23N4O9P | ||
ECMDB24059 | FMNH2 | {[(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-1H,2H,3H,4H,5H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl]oxy}phosphonic acid | 458.3597 C17H23N4O9P | ||
ECMDB04169 | UDP-N-Acetylmuramoyl-L-alanyl-D-glutamate 17088-64-1 | (2R)-2-({2-[(2-{[(3R,4R,5S,6R)-2-({[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-5-hydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-4-yl]oxy}-1-hydroxypropylidene)amino]-1-hydroxypropylidene}amino)pentanedioic acid | 459.41 C22H32Cl2N2O4 | ||
ECMDB01396 | 5-Methyltetrahydrofolic acid 134-35-0 | (2S)-2-{[4-({[(6S)-2-amino-5-methyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]formamido}pentanedioic acid | 459.4558 C20H25N7O6 | ||
ECMDB24740 | DG(10:0(3-OH)/12:0(3-OH)/0:0) | (2S)-2-hydroxy-3-[(3-hydroxydecanoyl)oxy]propyl 3-hydroxydodecanoate | phospholipid biosynthesis (CL(10:0(3-OH)/12:0(3-OH)/10:0(3-OH)/12:0(3-OH))) PW001900 | 460.652 C25H48O7 | |
ECMDB23209 | TDP | 3-[(6-imino-2-methyl-1,6-dihydropyrimidin-5-yl)methyl]-4-methyl-5-{2-[(phosphono phosphonato)oxy]ethyl}-1,3-thiazol-3-ium hydrochloride | 460.767 C12H19ClN4O7P2S | ||
ECMDB21239 | L-Alanine-D-glutamate-meso-2,6-diaminoheptanedioate-D-alanine | 2-[(2-amino-1-hydroxypropylidene)amino]-6-({4-[(2-amino-1-hydroxypropylidene)amino]-4-carboxy-1-hydroxybutylidene}amino)heptanedioic acid | 461.4668 C18H31N5O9 | ||
ECMDB21240 | L-alanine-D-glutamate-meso-2,6-diaminoheptanedioate | 2-[(2-amino-1-hydroxypropylidene)amino]-6-({4-[(2-amino-1-hydroxypropylidene)amino]-4-carboxy-1-hydroxybutylidene}amino)heptanedioic acid | 461.4668 C18H31N5O9 | ||
ECMDB23212 | 2-methoxy-6-(all-trans-hexaprenyl)phenol | 2-methoxy-6-(3-methylbut-2-en-1-yl)phenol | 462.7064 C32H46O2 | ||
ECMDB01332 | Adenylsuccinic acid 19046-78-7 | (2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic acid | 463.2934 C14H18N5O11P | ||
ECMDB00998 | dCTP 2056-98-6 | ({[({[(2R,3S,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid | 467.1569 C9H16N3O13P3 | ||
ECMDB21527 | Deoxycytidine 5'-triphosphate 2056-98-6 | ({[({[(2S,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid | 467.1569 C9H16N3O13P3 | ||
ECMDB23845 | alpha-D-Ribose 1-methylphosphonate 5-triphosphate | ({[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-{[hydroxy(methyl)phosphoryl]oxy}oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid | methylphosphonate degradation I PW002065 | 468.073 C6H16O16P4 | |
ECMDB01191 | Deoxyuridine triphosphate 1173-82-6 | ({[({[(2R,3S,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid | Pyrimidine metabolism PW000942 | 468.1417 C9H15N2O14P3 | |
ECMDB23244 | DG(10:0/15:0/0:0) | (2S)-3-(decanoyloxy)-2-hydroxypropyl pentadecanoate | 470.735 C28H54O5 | ||
ECMDB23268 | DG(15:0/10:0/0:0) | (2R)-3-(decanoyloxy)-2-hydroxypropyl pentadecanoate | 470.735 C28H54O5 | ||
ECMDB23877 | Secondary alcohol | (2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)-9H-purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide | Fatty acid metabolism PW000796 | 471.5096 C22H29N7O5 | |
ECMDB24753 | DG(12:0(3-OH)/12:0/0:0) | (2R)-3-(dodecanoyloxy)-2-hydroxypropyl 3-hydroxydodecanoate | phospholipid biosynthesis (CL(12:0(3-OH)/12:0/12:0/12:0)) PW001917 | 472.707 C27H52O6 | |
ECMDB24763 | DG(12:0/12:0(3-OH)/0:0) | (2S)-3-(dodecanoyloxy)-2-hydroxypropyl 3-hydroxydodecanoate | phospholipid biosynthesis (CL(12:0/12:0(3-OH)/12:0/12:0)) PW001929 | 472.707 C27H52O6 | |
ECMDB00972 | N10-Formyl-THF 2800-34-2 | (2S)-2-{[4-(N-{[(6R)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}formamido)phenyl]formamido}pentanedioic acid | 473.4393 C20H23N7O7 | ||
ECMDB01562 | N5-Formyl-H4F 58-05-9 | 2-[(4-{[(2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid | 473.4393 C20H23N7O7 | ||
ECMDB24072 | N5-Formyl-THF | 2-[(4-{[(2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid | 473.4393 C20H23N7O7 |